All postsTag/ADME
newest
PBPK Modeling in Pediatric Populations
BLOG

Modeling Monday, Part 3: PBPK Modeling to Support Clinical Studies in Pediatric Populations

Meg GonsalvesJune 22, 2026
NON-COMPARTMENTAL ANALYSIS (NCA) Accurate Reproducible Results Regulatory Expertise Timely Deliverables Tailored Solutions NCA Services Our Non-Compartmental Analysis (NCA) of PK and PD data are designed to help you make informed, data-driven decisions quickly and accurately in real-time in your on-going studies or throughout your drug development lifecycle. Whether you're in clinical pharmacology, translational sciences, biometrics or clinical operation, precise understanding of absorption, distribution, metabolism and elimination (ADME) of your new drug candidate is critical. Our team delivers accurate results with a strong focus on budget efficiency and meeting deadlines. A left-skewed bell curve graph of plasma concentration over time after dose, with the area under the curve (AUC) and the time to reach the maximum concentration (Tmax and Cmax) highlighted. Meet Linh - our EVP of Clinical Pharmacology. Linh is head of our CP department. Prior to this, she was a Clinical Pharmacology leader at Amgen, Exelixis, Medivation, Pfizer, Arcus and Treadwell. She has also taken on many leadership roles such as DMPK, bioanalytical, PK/PD modeling, trial design and execution, and globally regulatory agency filings.
services

NCA Services - Here to Help You Make Informed, Data-Driven Decisions Quickly and Accurately in Real-Time

Simonne BruckApril 1, 2025